Prothena Corp PLC (STU:0PT)
€ 19.3 -0.2 (-1.03%) Market Cap: 1.04 Bil Enterprise Value: 542.33 Mil PE Ratio: 0 PB Ratio: 2.03 GF Score: 56/100

Prothena Corporation PLC at Morgan Stanley Global Healthcare Conference Transcript

Sep 11, 2023 / 06:15PM GMT
Release Date Price: €48.8 (-1.61%)
Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

Perfect. I think we'll get started with the next session. I'm Matthew Harrison, I guess, deemed recovering research analysts at this point. I work in investment banking at Morgan Stanley. Very pleased to have Prothena with us here. Just quickly before we get started, I need to read a disclosure statement. For important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/research disclosures. So really pleased to have Gene and Wagner here. Maybe I'll just turn it over to them to introduce themselves and then we can jump into Q&A.

Gene G. Kinney
Prothena Corporation plc - President, CEO & Director

Thank you very much. And first, thank you for having us. It's really nice to be here. Appreciate the opportunity to speak. I'm Gene Kinney. I'm the CEO of Prothena.

Wagner M. Zago
Prothena Corporation plc - Chief Scientific Officer

And I'm Wagner Zago, the CSO of Prothena, also glad to be here.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot